BMJ Submission Process

The process usually feels easiest when the manuscript already arrives with:

• a practical or policy consequence that is obvious quickly
• a title, abstract, and first display that support the same main claim
• an evidence package that feels complete enough for a general-medical screen
• reporting, PPI, and disclosure materials that already look stable

If those pieces are soft, the process can feel abrupt because the file will fail before external review becomes the main issue.

BMJ's author hub documents the actual early-stage path:

1. Awaiting Editorial Production Assistant Processing
2. Awaiting Editor Assignment
3. Awaiting Reviewer Selection
4. Peer Review in Progress
5. Awaiting Editor Decision
6. In Production

That matters because early silence is often not mysterious. It usually means quality checks, scope review, or reviewer recruitment rather than a paper disappearing into a black box.

BMJ's transfer service also changes the practical meaning of the process. Authors are now asked to select an alternate journal during submission, and if the paper is rejected it can move automatically to that destination together with files and peer reviews.

BMJ triage is not mainly testing whether the study is interesting.

It is testing whether:

• the paper is broad enough for a general-medical journal
• the consequence matters for practice, policy, or systems thinking now
• the package is complete enough to justify reviewer time
• the manuscript looks like it was actually prepared for this audience
• the transparency layer is strong enough for signed open review if the paper survives
• the paper should stay at The BMJ rather than being routed to a more appropriate BMJ title

That is why a fast rejection here often means "not broad or mature enough for BMJ," not "bad study."

The exact pace varies, but authors should think in stages:

• the earliest period is mostly editorial-fit and practice-consequence judgment
• movement into review usually means the hardest broad-audience screen has been cleared
• later slowdowns often reflect reporting, interpretation, or reviewer-alignment questions rather than admin delay

BMJ's generic peer-review workflow also explains two practical details many authors miss:

• for most articles, a minimum of two reviews are required
• reviewers are usually given two weeks once secured
• the journal may have to invite multiple reviewers before those two are locked in

The practical point is that the real risk sits early. If the manuscript survives that first editorial read, the conversation usually shifts from audience fit to whether the evidence package fully carries the practical claim.

Authors often frame the process as a portal problem: article type, files, declarations, cover letter, checklists.

Those mechanics matter, but the real process is editorial triage. BMJ is trying to decide whether the paper belongs in a general-medical conversation. A submission that would work in a narrower specialty journal can still fail quickly here even when every file is uploaded correctly.

So the useful lens is:

• the portal checks completeness
• the editor checks significance, breadth, and readiness

For BMJ specifically, there is also a third layer after rejection: transfer. BMJ now asks authors to choose an alternate journal during submission, and its transfer service says it has saved authors an average of 74 days from initial rejection to publication at another BMJ journal compared with publishing outside BMJ Group.

Before you enter the system, the package should already be stable.

That usually means:

• the article type is right
• the abstract states the clinical or policy consequence clearly
• reporting statements and declarations are complete
• tables and figures already look final
• the discussion explains why BMJ readers should care now

If the manuscript still depends on the cover letter to explain why it belongs in BMJ, it usually is not ready.

The mechanical submission path is standard enough: sign in, choose article type, enter metadata, upload files, complete declarations, and submit.

The more important issue is what the package signals while you do it.

If you are still making major framing choices while the portal is open, the manuscript is not finished enough for BMJ.

One operational detail matters here: if you opted into an alternate journal choice, BMJ says the paper will be automatically transferred after five days following rejection. That means the "next journal" decision is part of the live workflow, not an afterthought.

BMJ editors usually do not need much time to see whether a paper belongs in the journal.

They are often screening for:

• broad clinical or policy importance
• a result that changes more than one narrow specialty conversation
• enough completeness that peer review would debate implication rather than basic fit

This is why a technically solid manuscript can still fail very early. The problem is often not scientific competence. It is that the paper does not yet look like a BMJ paper.

In our pre-submission review work, BMJ submissions usually slow down when:

• the paper is medically important, but the readership case is still mostly specialty-specific
• the practical or policy consequence is asserted more clearly in the cover letter than in the manuscript itself
• reporting, PPI, or transparency materials are technically present but still feel under-finished
• the authors have not thought through the alternate-journal transfer path before submitting

The paper may be good medicine, but the readership case still belongs to a specialist journal rather than to a broad general-medical audience.

BMJ editors want to see what changes in practice, policy, or systems thinking. If that consequence is still vague, the process usually weakens fast.

If reporting is unstable, figures are messy, or the argument depends on future work, the paper looks premature.

Once the manuscript clears the first editorial screen, the process changes meaningfully.

At that stage, the paper is no longer mainly being judged on whether BMJ should look at it at all. It is being judged on whether the evidence is strong enough, whether the inference holds, and whether reviewers believe the consequences are proportionate.

That is a better kind of problem.

The most practical way to think about timing is in phases:

The lesson is simple: if the fit is weak, the process usually resolves earlier.

Most early status labels are only useful when you translate them back into the real editorial question.

The biggest mistake is assuming that a general-medical journal process behaves like a specialist-journal process. BMJ is more likely to stop a paper early if the broad-reader case is not convincing enough.

For BMJ research papers, the process does not end with a private accept decision. The BMJ says accepted research papers carry public prepublication history, including signed reviewer comments, author responses, earlier manuscript versions, and for clinical trials the protocol.

That means the process question is not just whether the paper can survive review. It is whether the review history will strengthen the paper once it is public.

The BMJ process usually weakens for predictable reasons:

• the title and abstract still sound like a specialty paper
• the cover letter says "general importance" while the manuscript proves only narrower value
• the discussion claims practice or policy consequences that outrun the data
• reporting items are technically complete but the package still feels under-finished
• the manuscript makes clinicians work too hard to see why they should care
• the alternate-journal choice was never thought through, so a predictable reject-with-transfer becomes a wasted cycle

Those failures matter because BMJ editors are triaging for reader importance, not only scientific correctness.

BMJ authors usually lose time in avoidable ways:

• submitting while the readership case is still blurry
• treating reporting checklists as last-minute administration instead of part of the editorial trust signal
• using a generic cover letter that could fit any medical journal
• waiting for an editorial decision before defining a realistic backup shortlist

The practical point is simple: if the manuscript still needs a deeper audience decision, the portal is not the next task.

The BMJ submission process should not be understood as a portal workflow alone. It is an editorial filter that starts the moment the manuscript package is visible.

That means the most useful preparation is not faster uploading. It is making the journal fit, practical importance, and reporting completeness obvious before the first click.